1. Search Result
Search Result
Results for "

PRLR

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

4

Inhibitory Antibodies

7

Recombinant Proteins

2

Antibodies

4

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99238

    ADC Antibody Inflammation/Immunology Cancer
    Rolinsatamab is a IgG1κ type chimeric antibody targeting to PRLR (prolactin receptor). Rolinsatamab can be conjugated with pyrrolobenzodiazepine (PDB) dimer SGD-1882 (HY-101127) via a cleavable maleimidocaproyl type linker, to form an antibody-drug conjugate, Rolinsatamab talirine. One Rolinsatamab talirine has an average of 2 site-specific drug attachment engineered cysteines (S239C). The linker equips the valine-alanine dipeptide, as cathepsine B cleavage site. on an average of 2 site-specific drug attachment engineered cysteines (S239C) .
    Rolinsatamab
  • HY-P991358

    LFA-102; X213

    Estrogen Receptor/ERR STAT Akt Cancer
    XOMA-213 (LFA-102; X213) is a human monoclonal antibody (mAb) targeting the prolactin receptor (PRLR), with a Kd value of 2 nM against the human target. XOMA-213 blocks PRL-induced cell proliferation and inhibits the activation of multiple PRLR ligands, including PRL and human growth hormone (hGH). XOMA-213 suppresses PRL-induced phosphorylation of Stat5, Akt and ERK1/2 in cells. XOMA-213 induces tumor regression, delays disease progression, and inhibits PRLR signaling as well as tumor growth. XOMA-213 can be used in research related to breast cancer .
    XOMA-213
  • HY-P99881

    ABBV 176

    Drug-Linker Conjugates for ADC Cancer
    Rolinsatamab talirine (ABBV 176) is an antibody-drug conjugate (ADC) targeting prolactin receptor (PRLR). Rolinsatamab talirine consists of rolinsatamab (HY-P99238), an enzymatically cleavable peptide linker, and SGD-1882 (HY-101127) .
    Rolinsatamab talirine
  • HY-RS11163

    Small Interfering RNA (siRNA) Others

    PRLR Human Pre-designed siRNA Set A contains three designed siRNAs for PRLR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    PRLR Human Pre-designed siRNA Set A
    PRLR Human Pre-designed siRNA Set A
  • HY-RS17413

    Small Interfering RNA (siRNA) Others

    Prlr Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prlr gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Prlr Mouse Pre-designed siRNA Set A
    Prlr Mouse Pre-designed siRNA Set A
  • HY-RS23867

    Small Interfering RNA (siRNA) Others

    Prlr Rat Pre-designed siRNA Set A contains three designed siRNAs for Prlr gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Prlr Rat Pre-designed siRNA Set A
    Prlr Rat Pre-designed siRNA Set A
  • HY-RS11411

    Small Interfering RNA (siRNA) Others

    PTP4A3 Human Pre-designed siRNA Set A contains three designed siRNAs for PTP4A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    PTP4A3 Human Pre-designed siRNA Set A
    PTP4A3 Human Pre-designed siRNA Set A
  • HY-P992449

    PRLR ADC antibody

    ADC Antibody Cancer
    REGN2878 (PRLR ADC antibody) is a monoclonal antibody targeting the prolactin receptor (PRLR) and can block prolactin‑mediated activation of PRLR. REGN2878 exhibits an equilibrium dissociation constant (KD) of 1.05 nM and an IC50 of 0.344 nM for human PRLR. REGN2878 can be rapidly internalized and degraded in lysosomes by PRLR‑positive tumor cells, showing antigen‑specific binding and targeted enrichment properties. REGN2878 derivatives can be used as an immunoPET agent for antigen‑specific imaging of PRLR‑related tumors, and can also serve as a component of ADCs to exert anti‑tumor activity in breast cancer xenograft models. REGN2878 can be used in the research of breast cancer and prostate cancer. Isotype Comparison HY-P99001 .
    REGN2878

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: